The noradrenergic system in Parkinson's disease

E Paredes-Rodriguez, S Vegas-Suarez… - Frontiers in …, 2020 - frontiersin.org
Nowadays it is well accepted that in Parkinson's disease (PD), the neurodegenerative
process occurs in stages and that damage to other areas precedes the neuronal loss in the …

Chronic pain in Parkinson's disease: clinical and pathophysiological aspects

A Marques, C Brefel-Courbon - Revue Neurologique, 2021 - Elsevier
Pain is an increasingly recognized non-motor symptom of Parkinson's disease (PD), with
significant prevalence and strong impact on quality of life of patients. Moreover, pain can …

Association of locus coeruleus and substantia nigra pathology with cognitive and motor functions in patients with Parkinson disease

J Prasuhn, M Prasuhn, A Fellbrich, R Strautz… - Neurology, 2021 - AAN Enterprises
Objective To investigate the contribution of substantia nigra (SN) and locus coeruleus (LC)
pathology to clinical signs and symptoms in Parkinson disease (PD) by applying …

Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats

AN Vivanco-Estela, M dos-Santos-Pereira… - …, 2021 - Elsevier
The musculoskeletal orofacial pain is a complex symptom of Parkinson's disease (PD)
resulting in stomatognathic system dysfunctions aggravated by the disease rigidity and …

Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice

Y Luan, D Tang, H Wu, W Gu, Y Wu… - Proceedings of the …, 2020 - National Acad Sciences
Although pain is a prevalent nonmotor symptom in Parkinson's disease (PD), it is
undertreated, in part because of our limited understanding of the underlying mechanisms …

Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson's disease

Y Buhidma, C Hobbs, M Malcangio, S Duty - npj Parkinson's Disease, 2023 - nature.com
Pain is a key non-motor feature of Parkinson's disease (PD) that significantly impacts on life
quality. The mechanisms underlying chronic pain in PD are poorly understood, hence the …

Effect of subthalamic stimulation and electrode implantation in the striatal microenvironment in a Parkinson's disease rat model

AC Pinheiro Campos, RCR Martinez… - International Journal of …, 2022 - mdpi.com
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is considered the gold-
standard treatment for PD; however, underlying therapeutic mechanisms need to be …

PACAP/PAC1-R activation contributes to hyperalgesia in 6-OHDA-induced Parkinson's disease model rats via promoting excitatory synaptic transmission of spinal …

L Dong, M An, H Gu, L Zhang, J Zhang, C Li… - Acta Pharmacologica …, 2023 - nature.com
Pain is a common annoying non-motor symptom in Parkinson's disease (PD) that causes
distress to patients. Treatment for PD pain remains a big challenge, as its underlying …

Byrsonima sericea Ethanol Extract Protected PC12 Cells from the Oxidative Stress and Apoptosis Induced by 6-Hydroxydopamine

ALC de Assis, P de Araújo Rodrigues… - Neurochemical …, 2024 - Springer
Parkinson's disease is characterized by the progressive loss of dopaminergic neurons in the
nigrostriatal pathway and oxidative stress is one of the main mechanisms that lead to …

[HTML][HTML] Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson's disease

F Sato, Y Nakamura, S Ma, T Kochi… - Biomedicine & …, 2022 - Elsevier
Parkinson's disease (PD) patients often complain of pain, but this problem has been
neglected and is poorly understood. High mobility group box-1 (HMGB1), an …